Showing 2791-2800 of 4167 results for "".
- Update: Revance Starts Phase III Studies on RT002 for Frown Lineshttps://modernaesthetics.com/news/revance-starts-phase-iii-studies-on-rt002-for-frown-lines/2472297/Revance Therapeutics began two double-blind, placebo-controlled, North American Phase III trials to evaluate single injections of DaxibotulinumtoxinA (RT002) for the treatment glabellar lines in about 600 total patients. These pivotal trials
- Revealed: What A Girl Wants in a Plastic Surgeonhttps://modernaesthetics.com/news/revealed-what-a-girl-wants-in-a-plastic-surgeon/2472307/Nearly half of all female plastic surgery patients have no preference when it comes to the gender of their cosmetic surgeon, a new study show. Specifically, the report, published in Aesthetic Surgery Journal</
- Recently Retired American Academy of Facial Plastic and Reconstructive Surgery CEO Receives AMA Lifetime Achievement Awardhttps://modernaesthetics.com/news/recently-retired-american-academy-of-facial-plastic-and-reconstructive-surgery-ceo-receives-ama-lifetime-achievement-award/2472317/The American Medical Association (AMA) has presented the Medical Executive Lifetime Achievement Award to Stephen C. Duffy, former executive vice president and CEO of the American Academy of Facial Plastic and Reconstructive Sur
- Syneron Candela's Profound SubQ FDA Approved to Improve Cellulitehttps://modernaesthetics.com/news/syneron-candelas-profound-subq-fda-approved-to-improve-cellulite/2472321/Syneron Candela received FDA 510(k) clearance for Profound when using the SubQ handpiece and cartridge to improve the appearance of cellulite in patients with Fitzpatrick skin types I-III, as supported by long term data (6 months). A recent multi-center clinical study of Profound sh
- Happy 30th, Botox!https://modernaesthetics.com/news/happy-30th-botox/2472832/Botox is turning 30, and Allergan fêted its shining star, Botox Cosmetic, in style at a New York City bash. The event included the debut of Botox Cosmetic’s new packaging and a panel discussion featuring New York City dermatologists Macrene Alexiades-Armenakas, MD, PhD
- AAD 2026: CO2 Laser Resurfacing Linked to Transient Microbiome Shiftshttps://modernaesthetics.com/news/aad-2026-co2-laser-resurfacing-linked-to-transient-microbiome-shifts/2486399/New findings presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, provide insight into dynamic microbiome changes following ablative CO2 laser resurfacing and their relationship to wound healing. In this monocentric, double-blind, rando
- BOTOX Cosmetic Selects Entrepreneurs for 2025 Confidence Projecthttps://modernaesthetics.com/news/botox-cosmetic-selects-entrepreneurs-for-2025-confidence-project/2475812/Allergan Aesthetics, an AbbVie company, announced the 2025 class of participants in The Confidence Project: Empowering Women Entrepreneurs, a national program led by BOTOX Cosmetic (onabotulinumtoxinA). The initiative is designed to address the confidence gap among women in business and
- Study Highlights Role of Patient-Reported Outcomes in Botulinum Toxin Developmenthttps://modernaesthetics.com/news/study-highlights-role-of-patient-reported-outcomes-in-botulinum-toxin-development/2475414/A patient-centric clinical approach, driven by the evolution of patient-reported outcomes (PROs), has been central to the development of onabotulinumtoxinA for aesthetic indications, according to new research in the Journal of Cosmetic Dermatology. Researchers concluded there is i
- Report: Stability for Cosmetic Surgeries, Minimally Invasive Treatments in 2024https://modernaesthetics.com/news/report-stability-for-cosmetic-surgeries-minimally-invasive-treatments-in-2024/2475393/
- New Avene Intensive Skin Restorative Serum Now Availablehttps://modernaesthetics.com/news/new-avene-intensive-skin-restorative-serum-now-available/2473645/